Dopaquinone (BioCAD00000010316)

feces

Metabolite Card

Formula: C9H9NO4 (195.0532)
SMILES: N[C@@H](CC1=CC(=O)C(=O)C=C1)C(O)=O

Synonyms [en]

Dopaquinone; (S)-2-Amino-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoate; O-Dopaquinone; L-dopaquinone; L-DOPA SEMIQUINONE; 4-(2-Carboxy-2-aminoethyl)-1,2-benzoquinone

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

Dopaquinone. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000010316). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

Dopaquinone, also known as o-dopaquinone or L-dopaquinone, is a member of the class of compounds known as L-alpha-amino acids. L-alpha-amino acids are alpha-amino acids which have the L-configuration of the alpha-carbon atom. Dopaquinone is slightly soluble (in water) and a moderately acidic compound (based on its pKa). L-Dopaquinone is a metabolite of L-DOPA and a precursor of melanin. Melanin is synthesized from tyrosine by hydroxylation to dihydroxyphenylalanine (DOPA) and subsequent oxidation to dopaquinone. Both reactions are catalyzed by the enzyme tyrosinase, which is the rate-limiting step. Dopaquinone has an ortho-quinone ring, which is known to be neurotoxic and highly reactive with many other compounds (PMID: 413870). Dopaquinone typically combines with cysteine to form pheomelanin (a pigment-polymer). Alternatively, dopaquinone can be converted to leucodopachrome and eventually to eumelanin (also a pigment-polymer). Dopaquinone can be found in skin and feces. Within the cell, dopaquinone is primarily located in the cytoplasm. Dopaquinone is involved in several metabolic disorders, some of which include transient tyrosinemia, hawkinsinuria, tyrosinemia type I, and alkaptonuria. Chronically high levels of dopaquinone are associated with Parkinson's disease (PD). Many Parkinson's patients are treated with L-DOPA. However, long-term treatment with L-DOPA may actually worsen symptoms or result in neurotic and psychotic symptoms. These may be due to dopachrome and dopaquinone accumulating in the brain of L-DOPA treated patients (PMID: 19131041, PMID: 12373519).

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 25520-73-4
  • CAS Registry Number: 4430-97-1
  • PubChem: 439316
  • ChEBI: ChEBI:16852
  • HMDB: HMDB0001229
  • KEGG: C00822
  • BioCyc: DOPAQUINONE
  • NCBI MeSH: dopaquinone
  • Wikipedia: L-Dopaquinone
  • RefMet: RM0136078
  • Metlin: METLIN_354
  • Coconut NaturalProduct: CNP0118108.1

Class / Ontology

Metabolic Network
ID EC Number Name
KEGG:R00045 1.10.3.1 3,4-dihydroxy-L-phenylalanine:oxygen oxidoreductase
KEGG:R02078 1.10.3.1 L-tyrosine,L-dopa:oxygen oxidoreductase
KEGG:R02962 C00822<=>C05604
KEGG:R03672 C01693 + C00355<=>C05604 + C00822
KEGG:R08848 C00822 + C00097<=>C17935
BioCyc:RXN-13061 1.10.3.- 2 L-DIHYDROXY-PHENYLALANINE + OXYGEN-MOLECULE --> 2 DOPAQUINONE + 2 WATER
BioCyc:RXN-14185 DOPAQUINONE + CYS --> CPD-15154
BioCyc:RXN-18894 CPD-20260 + DOPAQUINONE --> CPD-20261 + L-DIHYDROXY-PHENYLALANINE
BioCyc:MONOPHENOL-MONOOXYGENASE-RXN 1.14.18.1 TYR + OXYGEN-MOLECULE --> DOPAQUINONE + WATER
BioCyc:RXN-18899 DOPAQUINONE + CYS --> CPD-20260
BioCyc:RXN-18895 CPD-15154 + DOPAQUINONE --> CPD-20262 + L-DIHYDROXY-PHENYLALANINE
BioCyc:RXN-8483 DOPAQUINONE --> PROTON + CPD-8652
BioCyc:RXN-11369 CPD-8652 + DOPAQUINONE --> L-DOPACHROME + L-DIHYDROXY-PHENYLALANINE
View More
Organism Source

Taxonomy Source

  1. Homo sapiens [ncbi taxid: 9606]
  2. Mus musculus [ncbi taxid: 10090]

Pathway Synthetic

pathway id name
WikiPathways:WP3155 Dopamine metabolism
WikiPathways:WP3604 Biochemical pathways: part I
WikiPathways:WP3998 Prader-Willi and Angelman syndrome
WikiPathways:WP2436 Dopamine metabolism
WikiPathways:WP4941 GPR143 in melanocytes and retinal pigment epithelium cells
PathBank:SMP0120674 Alkaptonuria
PathBank:SMP0120782 Dopamine beta-Hydroxylase Deficiency
PathBank:SMP0000190 Hawkinsinuria
PathBank:SMP0087450 Tyrosine Metabolism
PathBank:SMP0120729 Tyrosinemia Type I
PathBank:SMP0120817 Monoamine Oxidase-A Deficiency (MAO-A)
PathBank:SMP0120491 Hawkinsinuria
PathBank:SMP0000169 Alkaptonuria
PathBank:SMP0000429 Disulfiram Action Pathway
PathBank:SMP0063684 Tyrosine Metabolism
PathBank:SMP0120453 Alkaptonuria
PathBank:SMP0120509 Tyrosinemia Type I
PathBank:SMP0120598 Monoamine Oxidase-A Deficiency (MAO-A)
PathBank:SMP0000218 Tyrosinemia Type I
PathBank:SMP0000533 Monoamine Oxidase-A Deficiency (MAO-A)
View All Pathways